Corrigendum to "EBV-LMP1 suppresses the DNA damage response through DNA-PK/AMPK signaling to promote radioresistance in nasopharyngeal carcinoma" [Cancer Lett. 380 (1) (2016 Sep 28) 191–200]. (1st May 2017)